Biogen (BIIB) EV to EBIT (2009 - 2026)
Biogen's EV to EBIT was 72.09 in Q3 2026, up 727.3% from 8.71 a year earlier and up 138.0% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) EV to EBIT (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Biogen's EV to EBIT was 51.01 through Sep 30, 2026, up 996.4% year-over-year; for FY2025, it came in at 14.15, up 35.4% from FY2024.
- In earlier years, EV to EBIT was 10.45 in FY2024 (-62.8%), 28.10 in FY2023 (+188.6%), 9.74 in FY2022 (-12.3%) and 11.10 in FY2021 (+45.6%).
- The Q3 2026 figure marks the highest quarterly EV to EBIT in data going back to Q1 2009.
- Compared with a year earlier, EV to EBIT has increased for four straight quarters, with growth averaging 103.8% over the last eight quarters.
- The best year-over-year quarter for EV to EBIT over five years was Q3 2026 (growth of 727.3%); the worst was Q2 2022 (a decline of 65.6%).
- Per Business Quant data, BIIB's EV to EBIT in the three quarters before Q3 2026 was 30.29 (Q2 2026), 14.04 (Q1 2026) and 14.15 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 72.09 |
| Jun 30, 2026 | 30.29 |
| Mar 31, 2026 | 14.04 |
| Dec 31, 2025 | 14.15 |
| Sep 30, 2025 | 8.71 |
| Jun 30, 2025 | 8.71 |
| Mar 31, 2025 | 9.96 |
| Dec 31, 2024 | 10.45 |
| Sep 30, 2024 | 13.93 |
| Jun 30, 2024 | 24.25 |
| Mar 31, 2024 | 22.91 |
| Dec 31, 2023 | 28.10 |
| Sep 30, 2023 | 21.72 |
| Jun 30, 2023 | 11.27 |
| Mar 31, 2023 | 9.56 |
| Dec 31, 2022 | 9.07 |
| Sep 30, 2022 | 8.74 |
| Jun 30, 2022 | 7.60 |
| Mar 31, 2022 | 10.93 |
| Dec 31, 2021 | 11.10 |
API Access
Biogen EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();